Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12951307 | 0.91 | CCR2 (1.00) | CCR2ADRA1D | |
| SCHEMBL11879154 | 0.86 | CCR2 (0.77) | CCR2ADRA1D | |
| SCHEMBL3113930 | 0.83 | CCR2 (0.58) | CCR2 | |
| SCHEMBL11878825 | 0.82 | CCR2 (0.70) | CCR2 | |
| SCHEMBL11879694 | 0.81 | CCR2 (0.75) | CCR2ADRA1D | |
| SCHEMBL28321344 | 0.81 | CCR2 (0.55) | CCR2 | |
| Succinic Acid SCHEMBL11876332 | 0.78 | CCR2 (0.68) | CCR2 | |
| SCHEMBL5705215 | 0.78 | CCR2 (0.73) | CCR2 | |
| SCHEMBL6133832 | 0.77 | CCR2 (0.66) | CCR2ADRA1D | |
| SCHEMBL24076756 | 0.77 | CCR2 (0.66) | CCR2ADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104987326-B | The set of reactive mass labels | 电泳有限公司 | 2019-08-30 | — | — | CN | disclosed |
| US-9023656-B2 | Reactive mass labels | ELECTROPHORETICS LIMITED (GB) | 2015-05-05 | — | — | US | disclosed |
| US-20100178710-A1 | Mass Labels | ELECTROPHORETICS LIMITED (GB) | 2010-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100178710-A1 | Mass Labels | B2M, SRRM2, CCNB1 | CCR2 73/4885ADRA1D 3514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.